Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

NCT07626411 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

15364

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation (AF)

Interventions

DRUG: REGN7508
DRUG: Apixaban
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals